Researchers at West Virginia University have uncovered critical data showing bariatric surgery as a treatment method for patients with nonalcoholic fatty liver disease has a significant impact on improving clinical outcomes. ...
May 3, 2023
0
36
Adding the right prebiotic to the diets of pediatric patients with intestinal failure could replace intravenous feeding, says a new University of Illinois study.
Oct 15, 2012
0
0
Dyskeratosis congenita, or DC, is a rare, inherited disease for which there are limited treatment options and no cure. Typically diagnosed in childhood, the disorder causes stem cells to fail, leading to significant problems ...
Aug 18, 2016
0
25
Pioneering scientists at the Francis Crick Institute, Great Ormond Street Hospital (GOSH) and UCL Great Ormond Street Institute of Child Health (ICH) have grown human intestinal grafts using stem cells from patient tissue ...
Sep 8, 2020
0
43
In the E coli outbreak in Germany in May 2011, treatment with azithromycin was associated with a lower frequency of long-term carriage of the bacteria and shorter duration of shedding of the bacteria in stool specimens, according ...
Mar 13, 2012
0
0
Gastroschisis is a complex and costly birth condition that affects babies' bowels. Cases have doubled in the United States over the last two decades.
Aug 7, 2023
0
2
An investigational drug that blocks intestinal phosphate absorption may help reduce the dangerously high blood levels of phosphate commonly seen in patients with kidney failure. The findings appear in an upcoming issue of ...
Mar 7, 2019
0
1
A multi-center analysis, led by Weill Cornell Medical College and published in the Journal of Clinical Gastroenterology, shows the use of temporary "fully covered self-expanding metal stents" (FCSEMS) can effectively fix ...
Mar 20, 2013
0
0
Stem cells taken from amniotic fluid were used to restore gut structure and function following intestinal damage in rodents, in new research published in the journal Gut. The findings pave the way for a new form of cell therapy ...
Mar 24, 2013
0
0
(HealthDay)—Procysbi (cysteamine bitartrate) delayed-release capsules have been approved by the U.S. Food and Drug Administration to treat nephropathic cystinosis in children (6 years and up) and adults. Since it is intended ...
May 2, 2013
0
0
